National Health Investors (NYSE:NHI) Updates FY 2026 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 4.740-4.790 for the period, compared to the consensus EPS estimate of 4.870. The company issued revenue guidance of -.

National Health Investors Stock Down 1.4%

Shares of NYSE:NHI traded down $1.07 during midday trading on Monday, reaching $74.23. The company had a trading volume of 403,320 shares, compared to its average volume of 436,470. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The stock’s fifty day moving average price is $75.13 and its 200-day moving average price is $79.60. The stock has a market capitalization of $3.60 billion, a P/E ratio of 23.95, a PEG ratio of 3.38 and a beta of 0.51. National Health Investors has a one year low of $67.94 and a one year high of $91.38.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Truist Financial decreased their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a report on Friday, June 12th. Deutsche Bank Aktiengesellschaft cut their target price on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a research report on Wednesday, April 22nd. Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Finally, Zacks Research lowered National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $83.86.

Insiders Place Their Bets

In other National Health Investors news, Director Robert A. Mccabe, Jr. purchased 890 shares of National Health Investors stock in a transaction dated Monday, June 15th. The shares were bought at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director owned 44,159 shares in the company, valued at $3,163,992.35. This represents a 2.06% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the acquisition, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On National Health Investors

Institutional investors have recently made changes to their positions in the stock. NewEdge Advisors LLC lifted its holdings in shares of National Health Investors by 28.7% in the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after purchasing an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in National Health Investors by 9.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock worth $18,460,000 after buying an additional 21,851 shares during the last quarter. Jane Street Group LLC increased its position in National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock worth $5,148,000 after buying an additional 65,885 shares during the period. Cetera Investment Advisers increased its position in National Health Investors by 6.1% in the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock worth $336,000 after buying an additional 275 shares during the period. Finally, American Century Companies Inc. lifted its stake in National Health Investors by 2.2% in the second quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock valued at $1,349,000 after buying an additional 420 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.